Increasing evidence indicates that NLRP3 is a pivotal pathogenic driver across multiple neurodegenerative diseases, with demonstrated involvement in Alzheimer’s disease (AD) [58], Parkinson’s disease (PD) [59], and MS [60]. The gene discussed is NLRP3; the disease is myeloid sarcoma.